NEO
USDNeoGenomics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$10.200
Haut
$10.317
Bas
$9.780
Volume
2.66M
Fondamentaux de l'Entreprise
Capitalisation Boursière
1.3B
Industrie
Diagnostics & Research
Pays
United States
Statistiques de Trading
Volume Moyen
3.47M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
Additional presentations to focus on liquid biopsy– MRD based detection and genomic profiling across solid tumors NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable
NeoGenomics Reports Third Quarter 2025 Results
Third quarter total revenue increased 12% YoY to $188 million Clinical revenue grew 18%, or 15% excluding the Pathline acquisition NGS revenue increased 24% YoY and now accounts for nearly one-third of clinical
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the presentation of assay-relevant data, including interventional therapy trials in
Actions Connexes
IDE
Voya Infrastructure Industrials and Materials Fund Common Shares of Beneficial Interest
APDN
Applied DNA Sciences Inc.
QRTEB
Qurate Retail Inc. Series B
ADT
ADT Inc.
SNCRL
Synchronoss Technologies Inc. 8.375% Senior Notes due 2026
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.